Delivery Order SPE2DB20D2104-SPE2DB25FMRTT
Award Date
5/27/25
Potential Completion Date
5/28/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,136.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed-price delivery order. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,041.48 firm fixed-price delivery order contract is for the supply of JANUMET 50-1,000 MG TABLET 60S, a medication used to treat diabetes. The contract has an ultimate completion date of June 26, 2024 and was awarded on June 25, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,086.66 firm fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,964.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication, with a performance period ending on March 3, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,420.50 firm fixed-price delivery order contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of August 30, 2022 and was awarded on August 29, 2022. This delivery order is part of a larger $999,999,999...
This federal contract award, valued at $7,432.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a completion date of February 7, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation indicated. Amerisourcebergen Drug Corp is the prime contractor, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,105.56 firm fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a diabetes medication. The contract has an ultimate completion date of March 18, 2025 and was awarded on March 17, 2025. This contract award is not associated with a set-aside program. AmerisourceBergen holds a...
This federal contract award, valued at $7,631.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of JANUMET 50-1,000 MG TABLET 60S, a prescription medication used in the treatment of diabetes. The contract has an ultimate completion date of December 12, 2023 and was awarded on December 11, 2022. The contract was not designated...
This federal contract award, valued at $1,928.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used in the management of diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 24, 2025. It is not designated as a set-aside contract....
This federal contract award, valued at $5,600.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 31, 2025. This award is associated with Amerisourcebergen's larger...